Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period
However, it's critical to understand that: No GLP-1 patch is currently approved for patient use
Side effects of AC include a black tongue and black stool, constipation, intestinal obstruction, aspiration pneumonitis, and vomiting
Patent number 4, 602, 039 The combination of l-Carnitine and CoQ10 is produced under a nonexclusive license from SIGMA-TAU/BIOSINT, U.S
Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB
US$ 25.38
US$ 26.15
US$ 25.86
US$ 24.02
US$ 21.67
US$ 23.46
US$ 22.59
US$ 26.01
US$ 24.62
